Comparable Long-Term Outcomes Among DAS28-ESR-based Remission Criteria and ACR/EULAR Definitions in Patients with Established Rheumatoid Arthritis

被引：0
|
作者：
Ramirez Garcia, Felipe Julio [1 ]
Inciarte-Mundo, Jose [2 ]
Cuervo, Andrea [3 ]
Celis, Raquel [3 ]
Ruiz-Esquide, Virginia [3 ]
Castellanos-Moreira, Raul [4 ]
Ponce, Andres [3 ]
Gomez-Puerta, Jose [2 ]
Sanmarti, Raimon [2 ]
Canete, Juan [1 ,5 ]
机构：
[1] Hosp Clin Barcelona, Arthrit Unit, Dept Rheumatol, Barcelona, Spain
[2] Hosp Univ Clin Barcelona, Barcelona, Catalonia, Spain
[3] Hosp Clin Barcelona, Barcelona, Spain
[4] Hosp Clin Barcelona, Barcelona, Spain
[5] IDIBAPS, Barcelona, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1756
引用
收藏
页数：3
相关论文
共 47 条
  • [31] Inheritance of the shared epitope and long-term outcomes of rheumatoid arthritis among community-based Caucasian females
    Criswell, LA
    Mu, H
    Such, CL
    King, MC
    GENETIC EPIDEMIOLOGY, 1998, 15 (01) : 61 - 72
  • [32] DAS28 remission and clinical efficacy in rheumatoid arthritis patients with inadequate responses to methotrexate treated with abatacept: The Phase III AIM trial and a Phase IIB trial long-term extension
    Westhovens, R
    Kremer, J
    Shergy, W
    Abud-Mendoza, C
    Aranda, R
    Becker, JC
    Zhou, Y
    Mokliatchouk, O
    Dougados, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S142 - S142
  • [33] Fast Remission Response to Etanercept At Week 4 Predicts Better Long-Term Outcomes in Early and Established Rheumatoid Arthritis Compared to Slower Response At Week 12.
    Raffeiner, Bernd
    Botsios, Costantino
    Ometto, Francesca
    Canova, Mariagrazia
    Bernardi, Livio
    Vezzari, Cristiana
    Todesco, Silvano
    Sfriso, Paolo
    Punzi, Leonardo
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S545 - S545
  • [34] Which treatments had been tapered or stopped in rheumatoid arthritis in long-term DAS28 remission following subcutaneous tumor-necrosis-factor blocker therapy? A retrospective experience on 43 patients
    Alla, Sanae Ali Ou
    Lukas, Cedric
    Hajjaj-Hassouni, Najia
    Flipo, Rene Marc
    Combe, Bernard
    Morel, Jacques
    JOINT BONE SPINE, 2012, 79 (05) : 520 - 521
  • [35] Radiological scores of rheumatoid arthritis among community-based caucasian females and their association with genotypes and long-term clinical outcomes.
    Jiang, Y
    Zhao, JJ
    Zhao, S
    Genant, HK
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S85 - S85
  • [36] DAS28 and decrease of serum osteoprotegerin from baseline level represent parameters predicting long-term efficacy intliximab plus methotrexate treatment in rheumatoid arthritis patients.
    Ziolkowska, M
    Wiland, P
    Szechinski, J
    Sliwinska, P
    Pazdur, J
    Rupinski, R
    Filipowicz-Sosnowska, A
    Maslinski, W
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S135 - S135
  • [37] Apremilast Is Associated with Long-Term DAS-28 (CRP) Remission and Improvements in Skin Disease: Results from a Phase III Study in DMARD/Biologic-Experienced Active Psoriatic Arthritis Patients
    Edwards, Christopher J.
    Blanco, Francisco J.
    Crowley, Jeffrey J.
    McIlraith, Melissa
    Shah, Kamal
    Delev, Nikolay
    Teng, Lichen
    Birbara, Charles A.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [38] Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy
    ten Klooster, Peter M.
    Voshaar, Martijn A. H. Oude
    Fakhouri, Walid
    de la Torre, Inmaculada
    Nicolay, Claudia
    van de Laar, Mart A. F. J.
    CLINICAL RHEUMATOLOGY, 2019, 38 (10) : 2727 - 2736
  • [39] Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy
    Peter M. ten Klooster
    Martijn A. H. Oude Voshaar
    Walid Fakhouri
    Inmaculada de la Torre
    Claudia Nicolay
    Mart A. F. J. van de Laar
    Clinical Rheumatology, 2019, 38 : 2727 - 2736
  • [40] STRICT ACR-REMISSION WITHIN 6 MONTHS PREDICTS SUSTAINED LONG-TERM VERY LOW DISEASE ACTIVITY IN ACTIVELY TREATED RHEUMATOID ARTHRITIS PATIENTS, 5-YEAR RESULTS OF THE NEO-RACO TRIAL
    Rantalaiho, V.
    Kautiainen, H.
    Korpela, M.
    Leirisalo-Repo, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 589 - 589
12345